NeuroOne Medical Technologies Corporation Cost of Revenue
NeuroOne Medical Technologies Corporation (NMTC) reported Cost of Revenue of $790.50 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation cost of revenue for the quarter ending 2026-06-30 was $790.50K, a 1.19% increase year-over-year.
- NeuroOne Medical Technologies Corporation cost of revenue for the quarter ending 2026-03-31 was $871.79K, a 41.64% increase year-over-year.
- NeuroOne Medical Technologies Corporation cost of revenue for the quarter ending 2025-12-31 was $1.32M, a 1.67% decline year-over-year.
- NeuroOne Medical Technologies Corporation cost of revenue for the quarter ending 2025-09-30 was $1.21M, a 823.86% increase year-over-year.
- NeuroOne Medical Technologies Corporation cost of revenue for fiscal 2025 was $3.96M, a 66.70% increase from fiscal 2024.
- NeuroOne Medical Technologies Corporation cost of revenue for fiscal 2024 was $2.37M, a 58.65% increase from fiscal 2023.
- NeuroOne Medical Technologies Corporation cost of revenue for fiscal 2023 was $1.50M, a 518.24% increase from fiscal 2022.
- NeuroOne Medical Technologies Corporation cost of revenue for fiscal 2022 was $241.96K, a 12.30% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 12 month | Cost of Revenue 52 month | Cost of Revenue 55 month | Cost of Revenue 58 month | Cost of Revenue 61 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $790.50K 10-Q · filed 2026-08-13 | $1.66M derived: sum of 2 quarters · filed 2026-08-13 | $2.99M 10-Q · filed 2026-08-13 | $4.20M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2026-03-31 | $871.79K 10-Q/A · filed 2026-06-12 | $1.10M 10-Q · filed 2026-05-12 | $2.20M 10-Q/A · filed 2026-06-12 | $2.43M 10-Q · filed 2026-05-12 | $3.41M derived: sum of 3 quarters · filed 2026-06-12 | $4.19M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $1.32M 10-Q · filed 2026-02-17 | $2.54M derived: sum of 2 quarters · filed 2026-02-17 | $3.32M derived: sum of 3 quarters · filed 2026-08-13 | $3.93M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-09-30 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $1.99M derived: sum of 2 quarters · filed 2026-08-13 | $2.61M derived: sum of 3 quarters · filed 2026-08-13 | $3.96M 10-K · filed 2025-12-17 | ||||||
| 2025-06-30 | $781.22K 10-Q · filed 2026-08-13 | $1.40M derived: sum of 2 quarters · filed 2026-08-13 | $2.74M 10-Q · filed 2026-08-13 | $2.88M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-03-31 | $615.49K 10-Q/A · filed 2026-06-12 | $1.96M 10-Q/A · filed 2026-06-12 | $2.09M derived: sum of 3 quarters · filed 2026-06-12 | $2.64M derived: sum of 4 quarters · filed 2026-06-12 | ||||||
| 2024-12-31 | $1.35M 10-Q · filed 2026-02-17 | $1.48M derived: sum of 2 quarters · filed 2026-02-17 | $2.02M derived: sum of 3 quarters · filed 2026-02-17 | $3.01M derived: sum of 4 quarters · filed 2026-02-17 | ||||||
| 2024-09-30 | $131.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $675.13K derived: sum of 2 quarters · filed 2025-12-17 | $1.66M derived: sum of 3 quarters · filed 2025-12-17 | $2.37M 10-K · filed 2025-12-17 | ||||||
| 2024-06-30 | $543.90K 10-Q · filed 2025-08-14 | $1.53M derived: sum of 2 quarters · filed 2025-08-14 | $2.24M 10-Q · filed 2025-08-14 | $2.79M derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | $986.88K 10-Q · filed 2025-05-13 | $1.70M 10-Q · filed 2025-05-13 | $2.25M derived: sum of 3 quarters · filed 2025-05-13 | $2.63M derived: sum of 4 quarters · filed 2025-05-13 | ||||||
| 2023-12-31 | $711.34K 10-Q · filed 2025-02-12 | $1.26M derived: sum of 2 quarters · filed 2025-02-12 | $1.65M derived: sum of 3 quarters · filed 2025-02-12 | $2.08M derived: sum of 4 quarters · filed 2025-02-12 | ||||||
| 2023-09-30 | $548.13K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $934.37K derived: sum of 2 quarters · filed 2024-12-17 | $1.37M derived: sum of 3 quarters · filed 2024-12-17 | $1.50M 10-K · filed 2024-12-17 | ||||||
| 2023-06-30 | $386.24K 10-Q · filed 2024-08-14 | $820.91K derived: sum of 2 quarters · filed 2024-08-14 | $947.80K 10-Q · filed 2024-08-14 | $1.03M derived: sum of 4 quarters · filed 2024-08-14 | ||||||
| 2023-03-31 | $434.67K 10-Q · filed 2024-05-14 | $561.56K 10-Q · filed 2024-05-14 | $645.41K derived: sum of 3 quarters · filed 2024-05-14 | $683.87K derived: sum of 4 quarters · filed 2024-05-14 | ||||||
| 2022-12-31 | $126.89K 10-Q · filed 2024-02-13 | $210.74K derived: sum of 2 quarters · filed 2024-02-13 | $249.20K derived: sum of 3 quarters · filed 2024-02-13 | $322.00K derived: sum of 4 quarters · filed 2024-02-13 | ||||||
| 2022-09-30 | $83.85K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $122.31K derived: sum of 2 quarters · filed 2023-12-15 | $195.12K derived: sum of 3 quarters · filed 2023-12-15 | $241.96K 10-K · filed 2023-12-15 | ||||||
| 2022-06-30 | $38.46K 10-Q · filed 2023-08-14 | $111.27K derived: sum of 2 quarters · filed 2023-08-14 | $158.11K 10-Q · filed 2023-08-14 | $223.58K derived: sum of 4 quarters · filed 2023-08-14 | ||||||
| 2022-03-31 | $72.81K 10-Q · filed 2023-05-12 | $119.65K 10-Q · filed 2023-05-12 | $185.12K derived: sum of 3 quarters · filed 2023-05-12 | $247.05K derived: sum of 4 quarters · filed 2023-05-12 | ||||||
| 2021-12-31 | $46.84K 10-Q · filed 2023-02-13 | $112.31K derived: sum of 2 quarters · filed 2023-02-13 | $174.25K derived: sum of 3 quarters · filed 2023-02-13 | $213.61K derived: sum of 4 quarters · filed 2023-02-13 | ||||||
| 2021-09-30 | $65.47K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $127.40K derived: sum of 2 quarters · filed 2022-12-22 | $166.76K derived: sum of 3 quarters · filed 2022-12-22 | $275.89K 10-K · filed 2022-12-22 | ||||||
| 2021-06-30 | $61.94K 10-Q · filed 2022-08-11 | $101.30K derived: sum of 2 quarters · filed 2022-08-11 | $210.43K 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | $39.36K 10-Q · filed 2022-05-12 | $148.49K 10-Q · filed 2022-05-12 | ||||||||
| 2020-12-31 | $109.13K 10-Q · filed 2022-02-14 | |||||||||
| 2014-09-30 | $2.14K 10-Q · filed 2014-11-19 | |||||||||
| 2014-06-30 | $2.14K 10-Q · filed 2014-08-18 | |||||||||
| 2014-03-31 | $2.14K 10-Q · filed 2014-05-20 | |||||||||
| 2013-12-31 | $2.14K 10-K/A · filed 2014-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |